Bayesian Methods in Practice: Experiences in the Pharmaceutical Industry

From MaRDI portal
Publication:3774792

DOI10.2307/2347264zbMath0635.62106OpenAlexW78553138MaRDI QIDQ3774792

No author found.

Publication date: 1986

Published in: Applied Statistics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.2307/2347264



Related Items

On large-sample parametric approaches for interval estimation of the \(ED_{90}\), An approach to evaluating sensitivity in Bayesian regression analyses. (With discussion), Prediction markets, Bayesian priors, and clinical trials, Bayesian methods for analysing ringing data, The Wasserstein impact measure (WIM): a practical tool for quantifying prior impact in Bayesian statistics, Extended Models for Quantal Response Data, Uses, Abuses and Misuses of Significance Tests in the Scientific Community: Won't the Bayesian Choice be Unavoidable?, A Bayesian approach to Weibull survival models -- application to a cancer clinical trial, Bayesian tests for the balanced two-way analysis of variance model, Goodness of fit for the logistic regression model using relative belief, Clinician preferences and the estimation of causal treatment differences. (With comments), Hierarchical Bayesian analysis of the carryover effect in two-period crossover designs, On the multivariate predictive distribution of multi-dimensional effective dose: a Bayesian approach, Kullback-leibler information approach to the optimum measurement point for bayesian estimation, Weak informativity and the information in one prior relative to another, Approximation of Bayesian predictive \(p\)-values with regression ABC, Incorporating Bayesian ideas into health-care evaluation, A Bayesian Approach to Finite Mixture Models in Bioassay via Data Augmentation and Gibbs Sampling and Its Application to Insecticide Resistance, A Bayesian Approach for Nonlinear Regression Models with Continuous Errors, Critical issues in different inferential paradigms, A weakly informative default prior distribution for logistic and other regression models, Bayesian index to compare assumed survival functions of two hazards following exponential distributions, Asymptotic properties of anoya bayes factors, Estimating treatment effects in clinical crossover trials